πŸ‡ΊπŸ‡Έ FDA
Patent

US 7227009

MT-SP1 polynucleotides and polypeptides

granted A61PA61P35/00

Quick answer

US patent 7227009 (MT-SP1 polynucleotides and polypeptides) held by Catalyst Biosciences, Inc. expires Mon May 31 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Catalyst Biosciences, Inc.
Grant date
Tue Jun 05 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 31 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61P, A61P35/00